1.
The Colorado BioScience Association Launches Its Colorado BioScience Institute To Support
Much Needed Educational & Workforce Programs For The State's Bioscience Industry
Colorado BioScience Association (CBSA) is officially launching the Colorado BioScience Institute (The Institute) today.
The CBSA leadership team has set a kick‐off goal of $100,000 for The Institute this year. The initial $20,000 raised,
including a generous matching gift from PhRMA of up to $5,000, will support the Colorado launch of one of its flagship
programs, the BioGENEius Challenge.
Denver, CO, January 7, 2013 ‐ Colorado BioScience Association (CBSA) is officially launching the Colorado BioScience
Institute (The Institute) today. The announcement is made by April Giles, CBSA President & CEO, who says, “The Institute
is a 501(c)3 non‐profit that our Association is establishing to provide educational and workforce programs for teachers,
students, bioscience professionals and the broader community." The Institute will create a framework to train the very
best young scientists and business entrepreneurs, as well as assist companies with the recruitment, retention and
attraction of these future bioscience employees and leaders.
“We are very proud to bring The Institute to Colorado — we've spent a year accessing the community’s needs and
developing the framework of the Institute. As the Education Chair of the CBSA's Board of Directors, I look forward to
developing The Institute into a renowned and integral piece of the bioscience ecosystem in the state and adding value to
our growing industry,” Mark Spiecker, CEO of Sharklet Technologies and Board Member for both CBSA and The Institute,
explains. The Institute was introduced to the CBSA membership and community supporters at its Annual Awards Dinner
held last month by Spiecker.
Further, according to Giles: “Our Board saw a need for The Institute as our industry continues to grow at 4.6%, out‐
pacing the national average. It is expected that Colorado will need to fill 232,000 Science, Technology, Engineering and
Mathematics (STEM)‐related jobs by 2018. CBSA's new Institute is the only non‐profit in Colorado that focuses
exclusively on all areas of the bioscience industry. ”
The CBSA leadership team has set a kick‐off goal of $100,000 for The Institute this year. The initial $20,000 raised,
including a generous matching gift from PhRMA up to $5,000, will support the Colorado launch of one of its flagship
programs, the BioGENEius Challenge. BioGENEius provides high school students the opportunity to compete and be
recognized for outstanding research in biotechnology. Participants in the first Colorado BioGENEius Challenge will be
able to compete with participants across the country. For more information about the U.S. National BioGENEius
program, visit: http://www.biotechinstitute.org/node/1440
The Institute has established these five overarching program areas that are critical to the future of bioscience in
Colorado:
1. Teachers—Providing teachers with practical knowledge and experience to enhance their content understanding and
classroom practice, especially related to Science, Technology, Engineering and Mathematics (STEM).
2. Professionals—Providing programs for experienced researchers, entrepreneurs, and business leaders to build
businesses and advance their careers in the bioscience industries.
3. Workforce Development—Providing classes, trainings programs, internships as a form of workforce recruitment and
development.
‐More‐

2.
Page 2
4. Secondary Students (9‐12)—Providing students with opportunities to explore careers in biotechnology and associated
industries.
5. Community—Creating broader awareness of the industry’s impact through partnerships with other organizations.
The Institute will also provide assistance to patient advocacy and disease‐related organizations to help build awareness
of their important work in Colorado.
Colorado BioScience Institute Leadership
The Institute will be led by the following Board of Directors:
 Steve Orndorff, Ph.D., CBSA Board Chair, President and CEO, Ariel Pharmaceuticals
 Derek Cole, CBSA Board Vice Chair, Vice President, Investor Relations & Corporate Communications, ARCA
Biopharma
 Jim Wilson, CBSA Board Treasurer, Partner, Ernst & Young
 John Dunning, CBSA Board Secretary, President & CEO, Clarimedix Inc.
 Mark Spiecker, CBSA Executive Committee, Education, Chief Executive Officer, Sharklet Technologies
 Nicole Garneau, Ph.D., CBSA Education Committee, Curator and Chair of the Health Sciences Department at
Denver Museum of Nature & Science
About Colorado BioScience Institute
The Institute is the foundation arm of the Colorado BioScience Association and will provide educational and workforce
programs for teachers, students, bioscience professionals and the broader community. The Colorado BioScience
Institute has applied for 501(c)(3) tax‐exempt status and its tax exemption is pending. Donations today are deductible if
501(c)(3) status is granted by t he IRS since the exemption is retroactive to when the application was filed in August
2012. For more information, visit http://www.CoBioInstitute.org.
Link to view The Institute's Video Overview: http://youtu.be/2qgVEgNTlwI
About Colorado BioScience Association
Celebrating ten years of supporting the Bioscience Industry in Colorado in 2013, the CBSA is a not‐for‐profit organization
providing services and support for Colorado's bioscience industry. With more than 350 members, CBSA actively works to
promote the growth of the industry by advocating for a better business environment, growing the state's biotech
workforce, fighting for policies that support a strong bioscience industry in the state, and speaking with a single voice on
behalf of the industry. For more information, visit http://www.cobioscience.com.
Contacts:
Mae Desaire, Director of Marketing, Colorado BioScience Association ‐ http://www.cobioscience.com – 720‐382‐5918,
mdesaire@cobioscience.com
Maggie Chamberlin Holben, APR, Absolutely Public Relations ‐ http://www.absolutelypr.com ‐ 303‐984‐9801,
maggie@absolutelypr.com